Search

everythinglearnresearchcommunity

for

Search:↓

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

HIV patients with lower CD4 T cell counts often have more skin problems.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Targeting specific T cells may help treat alopecia areata.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Blood count parameters are not reliable for predicting recurrent implantation failure.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Some breast cancer chemotherapy can cause permanent hair loss.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

The article explains how to diagnose and manage certain types of scarring hair loss.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.